(PharmaNewsWire.Com, May 09, 2017 ) Asia-Pacific Autoimmune Diagnostics Market research report, published by Market Data Forecast estimates that the market is growing with a CAGR of 4.00% to reach USD 2.54 billion by 2021, from USD 2.09 billion in 2016, which amounts to a cumulative growth of USD 0.45 billion.
Autoimmune diagnostics is used to detect a disease in its early stage which helps the patients to live their valuable lives to the fullest. Children can treat gastrointestinal pain and nausea through autoimmunity testing which quickly returns their life to normal.
Treatment and care of a patient can be improved by efficient autoimmunity testing which leaves a greater impact on the physician’s diagnostic decisions. The two basic products of this market are IFA and EIA. Indirect fluorescent antibody (IFA) procedure frequently uses a substrate, human epithelial cells. One of the examples of autoimmune disease that affects women more than men is rheumatoid arthritis. . Globally, most of the industrialized nations are spending a huge part of their GDP on healthcare necessities.
The report also presents detailed analysis of multitude of factors affecting the diagnostic imaging market bearing either positive or negative outcomes. Some of those factors are • Increasing autoimmune disorders awareness among public, • Establishing partnerships between clinical labs and physicians, • Improvised and automatized laboratory techniques, • Increasing prevalence of Graves and Hashimoto's Thyroid Disease, Rheumatoid arthritis, type 1diabetes and lupus, • Autoimmune diagnostic test reports are slowly turning around time, • Greater chances of false positive results.
For granular level understanding the Autoimmune Diagnostics Market is segmented based on test type, disease type and end-users, each being provided with Market Size Estimations and Y-o-Y Forecasts. Based on Test Type the market is segmented as Complete Blood Count (CBC), Autoantibody Tests, Antinuclear Antibody Tests, C - reactive protein (CRP), Comprehensive Metabolic panel, Urinalysis, Erythrocyte Sedimentation Rate (ESR) and others. Based on Disease Type the market is further segmented as Localized auto immune disease diagnostics (Graves’ disease, Hashimoto's Thyroiditis, Type 1 diabetes, Multiple Sclerosis, Psoriasis and Others) and systemic auto immune disease diagnostics (Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Ankylosing Spondylitis). Based on End-users the market is furthermore segmented as Hospitals, Research centres, and diagnostic laboratories.
With India and China being the major economies with unexplored customer base, have been covered in the study. The report also focuses on other regions like Japan, Australia, South Korea and Rest of Asia-Pacific. Rheumatoid arthritis is experienced in Asian American women at an increased rate and lupus is mostly experienced by woman of Asian origin as compared to women of other regions.
Some of the key players that operate in the Autoimmune Diagnostics market include F.Hoffmann-La Roche, Pfizer Inc., AstraZeneca, Novartis AG and Sanofi-aventis.
The Asia- Pacific Autoimmune Diagnostics market report offers wide-range of scope:
• Regional and country-level analysis that provides an individual perspective of Asia-Pacific region and the aforementioned countries
• Know more about key areas of industry growth via detailed Segment-level analysis on basis of test type, disease test, end-user along with market size forecasts and y-o-y estimations
• Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
• Strategic Analyses containing PESTLE and Porter’s Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics
• Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
For more reports related to the Diagnostics Market:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
